C.H. Robinson Worldwide Inc. (CHRW)

C.H. Robinson Worldwide Inc. (CHRW) is trading near the bottom of its 52-week range, at 8% of the distance from its low to its high, after a 22.90% fall over six months. The sell-off has come even as the company keeps beating earnings estimates: its adjusted EPS of $1.80 for the October 28, 2026 report beat the $1.75 estimate by 2.86%, and revenue grew 29.50% year on year in that quarter. The gap between operating results and the share price is the central question for investors now. The price sits below the 20-day, 50-day and 200-day averages, and the analysts' median 12-month target of $180.00 is well above where the stock trades.

C.H. Robinson has beaten EPS estimates in each of the last eight reports, the most recent on October 28, 2026, when adjusted EPS of $1.80 topped the $1.75 estimate by 2.86%. Yet the share price fell 0.13% in the first session after that report. The same pattern has repeated: four of the eight beats were followed by a lower share price in the first session.

Return on equity of 38.92% sits above the sector median of 17.8%. The net profit margin is thin at 3.67%, and the operating margin is 5.66%, so the business earns a small amount on each dollar of revenue even as its volume rises. Debt-to-equity stands at 1.36. Analysts expect EPS to grow 25.0% this fiscal year to $6.36 and 17.4% next year to $7.47, and expect revenue to rise 17.6% to $19.1B this year.

At a trailing P/E of 23.15, the stock trades 31.9% below the sector median P/E of 34.0. The price-to-sales ratio of 0.82 compares with a sector median of 4.0, a discount of 79.5%. Trailing GAAP EPS of $5.57 underpins the P/E. The discount is the clearest reason the valuation work in CleaRank's model comes out in the stock's favour, even though the share price has been falling.

Over the last 18 months, insiders sold $21.1M of stock across 12 sales and bought $401K of stock in three open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so the purchases are the more informative signal, though their size is small next to the sales.

The base case is that the stock keeps trading in a range while the moving averages turn over. For the price to recover its trend, it would need to reclaim the 20-day EMA at $133.89 and then the 50-day SMA at $142.81, and hold above them. Continued earnings beats and the 29.50% revenue growth would support that case. The analysts' median target of $180.00, with a range from $131.00 to $235.00, assumes a re-rating that the current trend has not yet shown. A break below the 52-week low of $122.21 would weaken the case, as would another quarter where the stock falls after a beat, as it did after the July 29, 2026 report, when it dropped 15.44% in the first session. The MACD line is negative, which means momentum has not yet turned.

Support: the 52-week low at $122.21 is the nearest level below the price and marks the lowest trading point over the past year. A break below it would take the stock to new lows for the period. Resistance: the 20-day EMA at $133.89 is the nearest level above the price, and a rise would meet it first. The 50-day SMA at $142.81 comes next and sits about 10.77% above the price's current level as measured against that average. The 200-day SMA at $167.88 is the longer-term hurdle, followed by the 52-week high at $210.33.